Medicofarma Biotech SA (INB) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

PLN Million ()

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.33

Return on Equity

-64.20%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-34.9%

6 Months

90.84%

1 Year

25.31%

2 Years

-57.45%

3 Years

-55.36%

4 Years

-69.7%

5 Years

-87.8%

Medicofarma Biotech SA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-39.73%

EBIT Growth (5y)

-208.01%

EBIT to Interest (avg)

-1.63

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.11

Tax Ratio

0.75%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

EV to EBITDA

EV to Capital Employed

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-54.58%

ROE (Latest)

-58.38%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

Bearish

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -100.00% vs 0.00% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -75.00% vs 33.33% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "-0.20",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.70",
          "val2": "-0.40",
          "chgp": "-75.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-2,680.20%",
          "chgp": "268.02%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 50.00% vs -81.40% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 32.35% vs -112.50% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.20",
          "val2": "0.80",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.50",
          "val2": "-0.60",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.30",
          "val2": "-3.40",
          "chgp": "32.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,707.60%",
          "val2": "-3,459.80%",
          "chgp": "175.22%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.00

0.20

-100.00%

Operating Profit (PBDIT) excl Other Income

-0.30

-0.20

-50.00%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.70

-0.40

-75.00%

Operating Profit Margin (Excl OI)

0.00%

-2,680.20%

268.02%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is -100.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -75.00% vs 33.33% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1.20

0.80

50.00%

Operating Profit (PBDIT) excl Other Income

-0.50

-0.60

16.67%

Interest

0.20

Exceptional Items

0.00

Consolidate Net Profit

-2.30

-3.40

32.35%

Operating Profit Margin (Excl OI)

-1,707.60%

-3,459.80%

175.22%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 50.00% vs -81.40% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 32.35% vs -112.50% in Dec 2023

All Annual Results

Company CV

About Medicofarma Biotech SA

Medicofarma Biotech SA

Pharmaceuticals & Biotechnology

InBook SA is a Poland-based company engaged in retail trade and information technology (IT) services. The Company sells a range of products via Internet, including books, records, films, games, watches and jewelry, among others, and it is also engaged in several Internet projects. It operates a number of online services, such as inbook.pl, an online bookstore; casiomarket.pl, citizen.pl, diesel-zegarek.pl, timemaster24.pl and e-zegarki.pl, all providing online sales of watches; goldmarket.pl, specialized in the trading of jewelry; foteria.pl, offering photography services and products; fotomyk.pl, an online photo gallery; and cud.pl, an online gift shop.

Company Coordinates

Company Details

Ul. Rozdzienskiego 11 , DABROWA GORNICZA None : 41-308

Tel: 48 32 2686405

http://www.inbook.com.pl

Registrar Details